IP Library Granted Patent US 8,785,190
Granted Patent B2
US 8,785,190 · App. 13/441,311 · Granted Jul 22, 2014

Methods and compositions for modulating peripheral immune function

Inventors: Mo Dao (Huntington Beach, CA); Casey C. Case (San Mateo, CA)
Assignee: SanBio, Inc.
A61K35/28C12N2501/2302C12N2501/42C12N2502/1358C12N5/0637
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,785,190
App. No.
13/441,311
Granted
Jul 22, 2014
Kind
B2
Abstract

Disclosed herein are cell preparations useful for modulating various peripheral immune functions, methods for making said cell preparations, and methods for their use.

Claims (16)

1. A method for modulating production of one or more cytokines by a T-lymphocyte (T-cell) or a monocyte; the method comprising:

contacting the T-cell or monocyte with an effective amount of SB623 cells;

wherein said contacting results in stimulation of the production of one or more anti-inflammatory cytokines and/or inhibition of production of one or more pro-inflammatory cytokines by the T-cell or the monocyte;

further wherein said SB623 cells are obtained by

(a) providing a culture of marrow adherent stromal cells;

(b) contacting the cell culture of step (a) with a polynucleotide comprising sequences encoding the Notch intracellular domain (NICD) wherein said polynucleotide does not encode a full-length Notch protein;

(c) selecting cells that comprise the polynucleotide of step (b); and

(d) further culturing the selected cells of step (c) in the absence of selection for the polynucleotide, such that said marrow adherent stromal cells are induced to form SB623 cells by expression of the NICD.

2. The method of claim 1 , wherein the pro-inflammatory cytokine is interferon gamma (IFN-γ).

3. The method of claim 1 , wherein the pro-inflammatory cytokine is tumor necrosis factor alpha (TNF-α).

4. The method of claim 1 , wherein the anti-inflammatory cytokine is interleukin-10 (IL-10).

5. The method of claim 1 , wherein the T cell is a helper T-cell.

6. The method of claim 5 , wherein the helper T-cell is a T H 1 cell.

7. The method of claim 1 , wherein the T-cell is a regulatory T-cell.

8. The method of claim 7 , wherein the regulatory T-cell is a T R 1 cell.

9. The method of claim 1 , wherein said modulation of cytokine production results in conversion of a T-cell population from one that is pro-inflammatory to one that is anti-inflammatory.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2012
From: DAO, MO; CASE, CASEY C.
To: SANBIO, INC.
Reel/Frame 028422/0516 →
Continuity (3)
Provisional Application 61516637 · Apr 6, 2011
Provisional Application 61541248 · Sep 30, 2011
Related Publication 20130095084A1 · Apr 18, 2013